<?xml version="1.0" encoding="UTF-8"?>
<ref id="B199-vaccines-08-00224">
 <label>199.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>W.J.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wong</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Gao</surname>
    <given-names>G.F.</given-names>
   </name>
  </person-group>
  <article-title>T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>137</volume>
  <fpage>82</fpage>
  <lpage>92</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.11.006</pub-id>
  <pub-id pub-id-type="pmid">27840203</pub-id>
 </element-citation>
</ref>
